434 related articles for article (PubMed ID: 28878081)
1. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
[TBL] [Abstract][Full Text] [Related]
3. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
4. Effect of foot-and-mouth disease virus 3C protease B2 β-strand proline mutagenesis on expression and processing of the P1 polypeptide using a plasmid expression vector.
Martel E; Forzono E; Kurker R; Clark BA; Neilan JG; Puckette M
J Gen Virol; 2019 Mar; 100(3):446-456. PubMed ID: 30702422
[TBL] [Abstract][Full Text] [Related]
5. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
[TBL] [Abstract][Full Text] [Related]
6. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
7. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
[TBL] [Abstract][Full Text] [Related]
8. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
9. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
10. A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice.
Xie Y; Gao P; Li Z
Biomed Res Int; 2016; 2016():7849203. PubMed ID: 27478836
[TBL] [Abstract][Full Text] [Related]
11. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
[TBL] [Abstract][Full Text] [Related]
12. Foliar extracts from transgenic tomato plants expressing the structural polyprotein, P1-2A, and protease, 3C, from foot-and-mouth disease virus elicit a protective response in guinea pigs.
Pan L; Zhang Y; Wang Y; Wang B; Wang W; Fang Y; Jiang S; Lv J; Wang W; Sun Y; Xie Q
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):83-90. PubMed ID: 18006078
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.
Ma W; Wei J; Wei Y; Guo H; Jin Y; Xue Y; Wang Y; Yi Z; Liu L; Huang J; Wang L
Arch Virol; 2014 Jul; 159(7):1715-22. PubMed ID: 24473707
[TBL] [Abstract][Full Text] [Related]
14. Low levels of foot-and-mouth disease virus 3C protease expression are required to achieve optimal capsid protein expression and processing in mammalian cells.
Polacek C; Gullberg M; Li J; Belsham GJ
J Gen Virol; 2013 Jun; 94(Pt 6):1249-1258. PubMed ID: 23364188
[TBL] [Abstract][Full Text] [Related]
15. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
[TBL] [Abstract][Full Text] [Related]
16. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
17. Effect of Foot-and-Mouth Disease Virus 2B Viroporin on Expression and Extraction of Mammalian Cell Culture Produced Foot-and-Mouth Disease Virus-like Particles.
Primavera V; Simmons J; Clark BA; Neilan JG; Puckette M
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146583
[TBL] [Abstract][Full Text] [Related]
18. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
19. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
